Vista Therapeutics is a company developing biomarker detection tools. Its NanoBioSensor platform designed for real-time, continuous flow detection and measurement of biomarkers, as well as identification and quantification of the concentration range of proteins, antibodies, nucleic acids (DNA, RNA, microRNAs), and single viral particles. It also provides software, nanowires, microscopic wires, measurement instruments, and functionalized NanoCards for target immobilization to quantitatively measure and provide kinetic analysis.